Axon Enterprise, Inc. AXON reported first-quarter 2025 adjusted earnings of $1.41 per share, which surpassed the Zacks Consensus Estimate of $1.27. The bottom line surged 22.6% year over year despite a significant rise in the cost of sales. Total revenues of $603.6 million surpassed the consensus estimate of $589 million and increased 31.3% year over year. The top line benefited from strong demand for TASER 10 and Axon Body 4. Growing demand for platform sensors also augmented the top-line results. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) AXON’s Q1 Business Segment Performance Effective first-quarter 2025, AXON realigned its business segments. The company now reports results under two business segments, namely Connected Devices and Software & Services. Connected Devices: The segment’s revenues jumped 26% year over year to $340.9 million, driven by growth in demand for TASER 10 devices and associated cartridges, and Axon Body 4 as well as growth in platform solutions. The adjusted gross margin decreased year over year to 52.8% from 54.1%. Software & Services: The segment’s revenues rose 39% year over year to $262.7 million. The uptick was driven by an increase in the aggregate number of users and growing adoption of premium add-on features by existing customers. The adjusted gross margin increased to 77.7% from 76.1% in the year-ago period due to a higher software mix. Axon Enterprise, Inc Price, Consensus and EPS Surprise Axon Enterprise, Inc price-consensus-eps-surprise-chart | Axon Enterprise, Inc Quote AXON’s Margin Profile Axon’s cost of sales increased 18.2% year over year to $237.9 million. Selling, general and administrative expenses increased 48% year over year to $223.5 million. Total operating expenses climbed 54.7% year over year to $374.5 million. The adjusted gross margin increased to 63.6% from 63.2% in the year-ago period. AXON’s Balance Sheet & Cash Flow At the end of first-quarter 2025, Axon had cash and cash equivalents of $1.09 billion compared with $454.8 million at December 2024-end. Long-term lease liabilities totaled $40 million compared with $41.4 million at 2024-end. In the first three months of 2025, the company generated net cash of $25.8 million from operating activities against $15.9 million in cash spent in the previous year. Adjusted free cash flow was $932 million in the first three months of 2025 compared with $32.1 million in the prior year. AXON’s Outlook for 2025 For 2025, Axon expects revenues to be in the band of $2.60-$2.70 billion compared with $2.55-$2.65 billion anticipated earlier. The metric indicates approximately 27% year-over-year growth at the midpoint. Adjusted EBITDA is expected to be in the range of $650-$675 million, implying an adjusted EBITDA margin of about 25%. The company expects capital expenditures to be between $160 million and $180 million. This includes investments in long-term research & development projects, continued capacity expansion, global facility build-outs and new product development. It anticipates stock-based compensation expenses to be in the range of $580-$630 million. Story Continues AXON’s Zacks Rank The company currently carries a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Performance of Other Companies AZZ Inc. AZZ came out with quarterly earnings of $0.98 per share in the second quarter of fiscal 2025 (ended March 2025), beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share a year ago. AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with year-ago revenues of $366.5 million. Valmont Industries VMI reported revenues of $969.31 million in the first quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share of $4.32 for the same period compare with $4.32 a year ago. The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate being $4.24 per share. Pentair plc PNR came out with quarterly earnings of $1.11 per share in the first quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share a year ago. Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Valmont Industries, Inc. (VMI):Free Stock Analysis Report AZZ Inc. (AZZ):Free Stock Analysis Report Pentair plc (PNR):Free Stock Analysis Report Axon Enterprise, Inc (AXON):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Axon's Q1 Earnings Top Estimates on Solid Software & Services Sales
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...